securities class action

Securities class action filed against NuScale Power over alleged false statements regarding ENTRA1 Energy's nuclear qualifications. Lead plaintiff deadline April 20, 2026.

Rosen Law Firm files securities class action against Enphase Energy over alleged misstatements on inventory, financials, and federal credit impacts. Deadline: April 20, 2026.

uniQure faces securities lawsuit for allegedly misrepresenting Huntington's study design approval and downplaying BLA delays. Investors must act by April 13, 2026.

CoreWeave faces securities class action over false demand statements and concealed supplier concentration risk. March 13, 2026 deadline for affected investors.

Rosen Law Firm urges Vistagen investors to join securities class action by March 16, 2026, over alleged misstatements regarding fasedienol and clinical trials.

Oracle faces securities lawsuit alleging false AI strategy disclosures. Rosen Law Firm urges investors to join class action before deadline for undisclosed capex increases.

Rosen Law Firm investigates $SAN following UK mortgage lender collapse. Stock tumbled 7.6% over two days amid potential financial exposure.

Rosen Law Firm investigates GSI Technology ($GSIT) for allegedly misleading claims about AI chip capabilities, following a 14.2% stock plunge on February 4, 2026.

Rosen Law Firm urges PomDoctor investors to join securities class action alleging fraud, stock manipulation, and insider selling. April 7, 2026 lead plaintiff deadline.

Picard Medical faces securities fraud lawsuit alleging stock manipulation through social media misinformation, insider dumping, and artificial trading. Investors have until April 13, 2026 to join class action.

$SDM investors must act by March 16, 2026 in securities class action alleging market manipulation, false statements, and insider trading violations.

Ultragenyx faces a securities class action alleging misrepresentations about its setrusumab drug's efficacy for osteogenesis imperfecta. Affected investors have until April 6, 2026 to serve as lead plaintiff.

Securities class action filed against $PYPL alleging false statements on 2027 financial targets and Branded Checkout growth. Lead plaintiff deadline April 20, 2026.

Rosen Law Firm urges $INO investors to join class action lawsuit alleging false statements about manufacturing deficiencies and regulatory prospects.

Rosen Law Firm pursues securities class action against $METC, alleging false statements about Brook Mine development progress. Lead plaintiff deadline set for March 31, 2026.

Hagens Berman sues Corcept Therapeutics for allegedly misleading investors about relacorilant's FDA prospects. Stock crashed 50% after Complete Response Letter.

Rosen Law Firm launches securities class action against $RR for allegedly false statements regarding non-existent Microsoft collaboration. Lead plaintiff deadline set for April 3, 2026.

Trip.com's stock fell 17% following Chinese antitrust probe disclosure. Securities litigation investigation launched to recover investor losses.

HUBG disclosed accounting errors understating transportation costs, prompting Q1-Q3 2025 restatement. Stock fell 18.3% on disclosure; law firm investigates shareholder claims.

REGENXBIO faces class action over alleged misleading statements about RGX-111 gene therapy. Investors who bought stock between February 2022 and January 2026 may seek compensation.